Glial fibrillary acidic protein and multiple sclerosis progression independent of acute inflammation

BACKGROUND: The clinical relevance of serum glial fibrillary acidic protein (sGFAP) concentration as a biomarker of MS disability progression independent of acute inflammation has yet to be quantified. OBJECTIVE: To test whether baseline values and longitudinal changes in sGFAP concentration are ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Xiaotong, Shen, Changyu, Teunissen, Charlotte E, Wessels, Mark, Zetterberg, Henrik, Giovannoni, Gavin, Singh, Carol M, Caba, Bastien, Elliott, Colm, Fisher, Elizabeth, de Moor, Carl, Belachew, Shibeshih, Gafson, Arie R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413790/
https://www.ncbi.nlm.nih.gov/pubmed/37317870
http://dx.doi.org/10.1177/13524585231176732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413790/
https://www.ncbi.nlm.nih.gov/pubmed/37317870
http://dx.doi.org/10.1177/13524585231176732

Ejemplares similares